BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8384356)

  • 21. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
    Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
    Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NM23-H1 and NM23-H2 gene expression in human renal tumors.
    Theisinger B; Engel M; Seifert M; Seitz G; Welter C
    Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amplification, clone and identification of the specific fragments of tumor metastasis-suppressor gene nm23-H1 and nm23-H2].
    Li C; Lu Y; Wang R
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Nov; 15(4):322-4. PubMed ID: 11479979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of nm23 expression are related to cell proliferation in human prostate cancer.
    Igawa M; Rukstalis DB; Tanabe T; Chodak GW
    Cancer Res; 1994 Mar; 54(5):1313-8. PubMed ID: 8118821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics.
    Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B; Raschellà G
    Med Pediatr Oncol; 2001 Jan; 36(1):93-6. PubMed ID: 11464913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
    Leone A; Flatow U; VanHoutte K; Steeg PS
    Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
    Lai WW; Wu MH; Yan JJ; Chen FF
    Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
    Lin LI; Lee PH; Wu CM; Lin JK
    Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
    Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.
    Seifert M; Seib T; Engel M; Dooley S; Welter C
    Biochem Biophys Res Commun; 1995 Oct; 215(3):910-4. PubMed ID: 7488060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
    Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
    Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of nm23-H1 in human meningioma cells.
    Wang SW; Yam HF; Yang L; Ng HK; Wang SL; Wu BQ; Wang ZH; Chew-Cheng SB; Chew EC
    Anticancer Res; 1997; 17(5A):3569-73. PubMed ID: 9413204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
    Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
    Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nm23-H1: a metastasis-associated gene.
    Tee YT; Chen GD; Lin LY; Ko JL; Wang PH
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):107-13. PubMed ID: 17197349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
    Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
    Martinez R; Venturelli D; Perrotti D; Veronese ML; Kastury K; Druck T; Huebner K; Calabretta B
    Cancer Res; 1997 Mar; 57(6):1180-7. PubMed ID: 9067290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.